Bromodomain Protein-directed Agents and MYC in Small Cell Lung Cancer

Chen, H.; Liu, H.; Qing, G. Targeting oncogenic Myc as a strategy for cancer treatment. Signal Transduct. Target. Ther., 2018, 3(1), 5.
[http://dx.doi.org/10.1038/s41392-018-0008-7] [PMID: 29527331]

Donati, G.; Amati, B. MYC and therapy resistance in cancer: Risks and opportunities. Mol. Oncol., 2022, 16(21), 3828-3854.
[http://dx.doi.org/10.1002/1878-0261.13319] [PMID: 36214609]

Duffy, M.J.; O’Grady, S.; Tang, M.; Crown, J. MYC as a target for cancer treatment. Cancer Treat. Rev., 2021, 94, 102154.
[http://dx.doi.org/10.1016/j.ctrv.2021.102154] [PMID: 33524794]

DePinho, R.; Mitsock, L.; Hatton, K.; Ferrier, P.; Zimmerman, K.; Legouy, E.; Tesfaye, A.; Collum, R.; Yancopoulos, G.; Nisen, P.; Kriz, R.; Alt, F. Myc family of cellular oncogenes. J. Cell. Biochem., 1987, 33(4), 257-266.
[http://dx.doi.org/10.1002/jcb.240330404] [PMID: 3034933]

Chan, K.I.; Zhang, S.; Li, G.; Xu, Y.; Cui, L.; Wang, Y.; Su, H.; Tan, W.; Zhong, Z. MYC oncogene: A druggable target for treating cancers with natural products. Aging Dis., 2023.
[PMID: 37450923]

Das, S.K.; Lewis, B.A.; Levens, D. MYC: A complex problem. Trends Cell Biol., 2023, 33(3), 235-246.
[http://dx.doi.org/10.1016/j.tcb.2022.07.006] [PMID: 35963793]

Nie, Z; Guo, C; Das, SK; Chow, CC; Batchelor, E; Simons, SS, Jnr Dissecting transcriptional amplification by MYC. Elife, 2020, 27(9), e52483.
[http://dx.doi.org/10.7554/eLife.52483]

Carroll, P.A.; Freie, B.W.; Mathsyaraja, H.; Eisenman, R.N. The MYC transcription factor network: Balancing metabolism, proliferation and oncogenesis. Front. Med., 2018, 12(4), 412-425.
[http://dx.doi.org/10.1007/s11684-018-0650-z] [PMID: 30054853]

Lin, C.Y.; Lovén, J.; Rahl, P.B.; Paranal, R.M.; Burge, C.B.; Bradner, J.E.; Lee, T.I.; Young, R.A. Transcriptional amplification in tumor cells with elevated c-Myc. Cell, 2012, 151(1), 56-67.
[http://dx.doi.org/10.1016/j.cell.2012.08.026] [PMID: 23021215]

Scagnoli, F.; Palma, A.; Favia, A.; Scuoppo, C.; Illi, B.; Nasi, S. A new insight into MYC action: Control of RNA polymerase II methylation and transcription termination. Biomedicines, 2023, 11(2), 412.
[http://dx.doi.org/10.3390/biomedicines11020412] [PMID: 36830948]

Guo, J.; Li, T.; Schipper, J.; Nilson, K.A.; Fordjour, F.K.; Cooper, J.J.; Gordân, R.; Price, D.H. Sequence specificity incompletely defines the genome-wide occupancy of Myc. Genome Biol., 2014, 15(10), 482.
[http://dx.doi.org/10.1186/s13059-014-0482-3] [PMID: 25287278]

Evan, G.I.; Wyllie, A.H.; Gilbert, C.S.; Littlewood, T.D.; Land, H.; Brooks, M.; Waters, C.M.; Penn, L.Z.; Hancock, D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 1992, 69(1), 119-128.
[http://dx.doi.org/10.1016/0092-8674(92)90123-T] [PMID: 1555236]

Kumari, A.; Folk, W.; Sakamuro, D. The dual roles of MYC in genomic instability and cancer chemoresistance. Genes, 2017, 8(6), 158.
[http://dx.doi.org/10.3390/genes8060158] [PMID: 28590415]

Welcker, M.; Orian, A.; Jin, J.; Grim, J.A.; Harper, J.W.; Eisenman, R.N.; Clurman, B.E. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci., 2004, 101(24), 9085-9090.
[http://dx.doi.org/10.1073/pnas.0402770101] [PMID: 15150404]

Yada, M.; Hatakeyama, S.; Kamura, T.; Nishiyama, M.; Tsunematsu, R.; Imaki, H.; Ishida, N.; Okumura, F.; Nakayama, K.; Nakayama, K.I. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J., 2004, 23(10), 2116-2125.
[http://dx.doi.org/10.1038/sj.emboj.7600217] [PMID: 15103331]

Brockmann, M.; Poon, E.; Berry, T.; Carstensen, A.; Deubzer, H.E.; Rycak, L.; Jamin, Y.; Thway, K.; Robinson, S.P.; Roels, F.; Witt, O.; Fischer, M.; Chesler, L.; Eilers, M. Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma. Cancer Cell, 2013, 24(1), 75-89.
[http://dx.doi.org/10.1016/j.ccr.2013.05.005] [PMID: 23792191]

Macek, P.; Cliff, M.J.; Embrey, K.J.; Holdgate, G.A.; Nissink, J.W.M.; Panova, S.; Waltho, J.P.; Davies, R.A. Myc phosphorylation in its basic helix–loop–helix region destabilizes transient α-helical structures, disrupting Max and DNA binding. J. Biol. Chem., 2018, 293(24), 9301-9310.
[http://dx.doi.org/10.1074/jbc.RA118.002709] [PMID: 29695509]

Bender, G.; Fahrioglu Yamaci, R.; Taneri, B. CRISPR and KRAS: A match yet to be made. J. Biomed. Sci., 2021, 28(1), 77.
[http://dx.doi.org/10.1186/s12929-021-00772-0] [PMID: 34781949]

Sears, R.; Nuckolls, F.; Haura, E.; Taya, Y.; Tamai, K.; Nevins, J.R. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev., 2000, 14(19), 2501-2514.
[http://dx.doi.org/10.1101/gad.836800] [PMID: 11018017]

Duda, P.; Akula, S.M.; Abrams, S.L.; Steelman, L.S.; Martelli, A.M.; Cocco, L.; Ratti, S.; Candido, S.; Libra, M.; Montalto, G.; Cervello, M.; Gizak, A.; Rakus, D.; McCubrey, J.A. Targeting GSK3 and associated signaling pathways involved in cancer. Cells, 2020, 9(5), 1110.
[http://dx.doi.org/10.3390/cells9051110] [PMID: 32365809]

Gregory, M.A.; Hann, S.R. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt’s lymphoma cells. Mol. Cell. Biol., 2000, 20(7), 2423-2435.
[http://dx.doi.org/10.1128/MCB.20.7.2423-2435.2000] [PMID: 10713166]

Sun, X.X.; Li, Y.; Sears, R.C.; Dai, M.S. Targeting the MYC ubiquitination-proteasome degradation pathway for cancer therapy. Front. Oncol., 2021, 11, 679445.
[http://dx.doi.org/10.3389/fonc.2021.679445] [PMID: 34178666]

Walz, S.; Lorenzin, F.; Morton, J.; Wiese, K.E.; von Eyss, B.; Herold, S.; Rycak, L.; Dumay-Odelot, H.; Karim, S.; Bartkuhn, M.; Roels, F.; Wüstefeld, T.; Fischer, M.; Teichmann, M.; Zender, L.; Wei, C.L.; Sansom, O.; Wolf, E.; Eilers, M. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature, 2014, 511(7510), 483-487.
[http://dx.doi.org/10.1038/nature13473] [PMID: 25043018]

Sabò, A.; Amati, B. Genome Recognition by MYC. Cold Spring Harb. Perspect. Med., 2014, 4(2), a014191.
[http://dx.doi.org/10.1101/cshperspect.a014191] [PMID: 24492846]

Nilsson, J.A.; Cleveland, J.L. Myc pathways provoking cell suicide and cancer. Oncogene, 2003, 22(56), 9007-9021.
[http://dx.doi.org/10.1038/sj.onc.1207261] [PMID: 14663479]

Loosveld, M.; Bonnet, M.; Gon, S.; Montpellier, B.; Quilichini, B.; Navarro, J.M.; Crouzet, T.; Goujart, M.A.; Chasson, L.; Morgado, E.; Picard, C.; Hernandez, L.; Fossat, C.; Gabert, J.; Michel, G.; Nadel, B.; Payet-Bornet, D. MYC fails to efficiently shape malignant transformation in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer, 2014, 53(1), 52-66.
[http://dx.doi.org/10.1002/gcc.22117] [PMID: 24249258]

Thomas, L.R.; Wang, Q.; Grieb, B.C.; Phan, J.; Foshage, A.M.; Sun, Q.; Olejniczak, E.T.; Clark, T.; Dey, S.; Lorey, S.; Alicie, B.; Howard, G.C.; Cawthon, B.; Ess, K.C.; Eischen, C.M.; Zhao, Z.; Fesik, S.W.; Tansey, W.P. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. Mol. Cell, 2015, 58(3), 440-452.
[http://dx.doi.org/10.1016/j.molcel.2015.02.028] [PMID: 25818646]

Boi, D.; Rubini, E.; Breccia, S.; Guarguaglini, G.; Paiardini, A. When just one phosphate is one too many: The multifaceted interplay between myc and kinases. Int. J. Mol. Sci., 2023, 24(5), 4746.
[http://dx.doi.org/10.3390/ijms24054746] [PMID: 36902175]

Struntz, N.B.; Chen, A.; Deutzmann, A.; Wilson, R.M.; Stefan, E.; Evans, H.L.; Ramirez, M.A.; Liang, T.; Caballero, F.; Wildschut, M.H.E.; Neel, D.V.; Freeman, D.B.; Pop, M.S.; McConkey, M.; Muller, S.; Curtin, B.H.; Tseng, H.; Frombach, K.R.; Butty, V.L.; Levine, S.S.; Feau, C.; Elmiligy, S.; Hong, J.A.; Lewis, T.A.; Vetere, A.; Clemons, P.A.; Malstrom, S.E.; Ebert, B.L.; Lin, C.Y.; Felsher, D.W.; Koehler, A.N. Stabilization of the Max homodimer with a small molecule attenuates Myc-driven transcription. Cell Chem. Biol., 2019, 26(5), 711-723.e14.
[http://dx.doi.org/10.1016/j.chembiol.2019.02.009] [PMID: 30880155]

Dang, C.V.; O’Donnell, K.A.; Zeller, K.I.; Nguyen, T.; Osthus, R.C.; Li, F. The c-Myc target gene network. Semin. Cancer Biol., 2006, 16(4), 253-264.
[http://dx.doi.org/10.1016/j.semcancer.2006.07.014] [PMID: 16904903]

Poole, C.J.; van Riggelen, J. MYC—master regulator of the cancer epigenome and transcriptome. Genes, 2017, 8(5), 142.
[http://dx.doi.org/10.3390/genes8050142] [PMID: 28505071]

Vízkeleti, L.; Spisák, S. Rewired metabolism caused by the oncogenic deregulation of MYC as an attractive therapeutic target in cancers. Cells, 2023, 12(13), 1745.
[http://dx.doi.org/10.3390/cells12131745] [PMID: 37443779]

Karadkhelkar, N.M.; Lin, M.; Eubanks, L.M.; Janda, K.D. Demystifying the druggability of the myc family of oncogenes. J. Am. Chem. Soc., 2023, 145(6), 3259-3269.
[http://dx.doi.org/10.1021/jacs.2c12732] [PMID: 36734615]

Chen, Y.; McGee, J.; Chen, X.; Doman, T.N.; Gong, X.; Zhang, Y.; Hamm, N.; Ma, X.; Higgs, R.E.; Bhagwat, S.V.; Buchanan, S.; Peng, S.B.; Staschke, K.A.; Yadav, V.; Yue, Y.; Kouros-Mehr, H. Identification of druggable cancer driver genes amplified across TCGA datasets. PLoS One, 2014, 9(5), e98293.
[http://dx.doi.org/10.1371/journal.pone.0098293] [PMID: 24874471]

Soucek, L.; Whitfield, J.R.; Sodir, N.M.; Massó-Vallés, D.; Serrano, E.; Karnezis, A.N.; Swigart, L.B.; Evan, G.I. Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev., 2013, 27(5), 504-513.
[http://dx.doi.org/10.1101/gad.205542.112] [PMID: 23475959]

Madden, S.K.; de Araujo, A.D.; Gerhardt, M.; Fairlie, D.P.; Mason, J.M. Taking the Myc out of cancer: Toward therapeutic strategies to directly inhibit c-Myc. Mol. Cancer, 2021, 20(1), 3.
[http://dx.doi.org/10.1186/s12943-020-01291-6] [PMID: 33397405]

Llombart, V.; Mansour, M.R. Therapeutic targeting of “undruggable” MYC. EBioMedicine, 2022, 75, 103756.
[http://dx.doi.org/10.1016/j.ebiom.2021.103756] [PMID: 34942444]

Kalkat, M.; De Melo, J.; Hickman, K.; Lourenco, C.; Redel, C.; Resetca, D.; Tamachi, A.; Tu, W.; Penn, L. MYC deregulation in primary human cancers. Genes, 2017, 8(6), 151.
[http://dx.doi.org/10.3390/genes8060151] [PMID: 28587062]

Schaub, F.X.; Dhankani, V.; Berger, A.C.; Trivedi, M.; Richardson, A.B.; Shaw, R.; Zhao, W.; Zhang, X.; Ventura, A.; Liu, Y.; Ayer, D.E.; Hurlin, P.J.; Cherniack, A.D.; Eisenman, R.N.; Bernard, B.; Grandori, C.; Caesar-Johnson, S.J.; Demchok, J.A.; Felau, I.; Kasapi, M.; Ferguson, M.L.; Hutter, C.M.; Sofia, H.J.; Tarnuzzer, R.; Wang, Z.; Yang, L.; Zenklusen, J.C.; Zhang, J.J.; Chudamani, S.; Liu, J.; Lolla, L.; Naresh, R.; Pihl, T.; Sun, Q.; Wan, Y.; Wu, Y.; Cho, J.; DeFreitas, T.; Frazer, S.; Gehlenborg, N.; Getz, G.; Heiman, D.I.; Kim, J.; Lawrence, M.S.; Lin, P.; Meier, S.; Noble, M.S.; Saksena, G.; Voet, D.; Zhang, H.; Bernard, B.; Chambwe, N.; Dhankani, V.; Knijnenburg, T.; Kramer, R.; Leinonen, K.; Liu, Y.; Miller, M.; Reynolds, S.; Shmulevich, I.; Thorsson, V.; Zhang, W.; Akbani, R.; Broom, B.M.; Hegde, A.M.; Ju, Z.; Kanchi, R.S.; Korkut, A.; Li, J.; Liang, H.; Ling, S.; Liu, W.; Lu, Y.; Mills, G.B.; Ng, K-S.; Rao, A.; Ryan, M.; Wang, J.; Weinstein, J.N.; Zhang, J.; Abeshouse, A.; Armenia, J.; Chakravarty, D.; Chatila, W.K.; de Bruijn, I.; Gao, J.; Gross, B.E.; Heins, Z.J.; Kundra, R.; La, K.; Ladanyi, M.; Luna, A.; Nissan, M.G.; Ochoa, A.; Phillips, S.M.; Reznik, E.; Sanchez-Vega, F.; Sander, C.; Schultz, N.; Sheridan, R.; Sumer, S.O.; Sun, Y.; Taylor, B.S.; Wang, J.; Zhang, H.; Anur, P.; Peto, M.; Spellman, P.; Benz, C.; Stuart, J.M.; Wong, C.K.; Yau, C.; Hayes, D.N.; Parker, J.S.; Wilkerson, M.D.; Ally, A.; Balasundaram, M.; Bowlby, R.; Brooks, D.; Carlsen, R.; Chuah, E.; Dhalla, N.; Holt, R.; Jones, S.J.M.; Kasaian, K.; Lee, D.; Ma, Y.; Marra, M.A.; Mayo, M.; Moore, R.A.; Mungall, A.J.; Mungall, K.; Robertson, A.G.; Sadeghi, S.; Schein, J.E.; Sipahimalani, P.; Tam, A.; Thiessen, N.; Tse, K.; Wong, T.; Berger, A.C.; Beroukhim, R.; Cherniack, A.D.; Cibulskis, C.; Gabriel, S.B.; Gao, G.F.; Ha, G.; Meyerson, M.; Schumacher, S.E.; Shih, J.; Kucherlapati, M.H.; Kucherlapati, R.S.; Baylin, S.; Cope, L.; Danilova, L.; Bootwalla, M.S.; Lai, P.H.; Maglinte, D.T.; Van Den Berg, D.J.; Weisenberger, D.J.; Auman, J.T.; Balu, S.; Bodenheimer, T.; Fan, C.; Hoadley, K.A.; Hoyle, A.P.; Jefferys, S.R.; Jones, C.D.; Meng, S.; Mieczkowski, P.A.; Mose, L.E.; Perou, A.H.; Perou, C.M.; Roach, J.; Shi, Y.; Simons, J.V.; Skelly, T.; Soloway, M.G.; Tan, D.; Veluvolu, U.; Fan, H.; Hinoue, T.; Laird, P.W.; Shen, H.; Zhou, W.; Bellair, M.; Chang, K.; Covington, K.; Creighton, C.J.; Dinh, H.; Doddapaneni, H.V.; Donehower, L.A.; Drummond, J.; Gibbs, R.A.; Glenn, R.; Hale, W.; Han, Y.; Hu, J.; Korchina, V.; Lee, S.; Lewis, L.; Li, W.; Liu, X.; Morgan, M.; Morton, D.; Muzny, D.; Santibanez, J.; Sheth, M.; Shinbrot, E.; Wang, L.; Wang, M.; Wheeler, D.A.; Xi, L.; Zhao, F.; Hess, J.; Appelbaum, E.L.; Bailey, M.; Cordes, M.G.; Ding, L.; Fronick, C.C.; Fulton, L.A.; Fulton, R.S.; Kandoth, C.; Mardis, E.R.; McLellan, M.D.; Miller, C.A.; Schmidt, H.K.; Wilson, R.K.; Crain, D.; Curley, E.; Gardner, J.; Lau, K.; Mallery, D.; Morris, S.; Paulauskis, J.; Penny, R.; Shelton, C.; Shelton, T.; Sherman, M.; Thompson, E.; Yena, P.; Bowen, J.; Gastier-Foster, J.M.; Gerken, M.; Leraas, K.M.; Lichtenberg, T.M.; Ramirez, N.C.; Wise, L.; Zmuda, E.; Corcoran, N.; Costello, T.; Hovens, C.; Carvalho, A.L.; de Carvalho, A.C.; Fregnani, J.H.; Longatto-Filho, A.; Reis, R.M.; Scapulatempo-Neto, C.; Silveira, H.C.S.; Vidal, D.O.; Burnette, A.; Eschbacher, J.; Hermes, B.; Noss, A.; Singh, R.; Anderson, M.L.; Castro, P.D.; Ittmann, M.; Huntsman, D.; Kohl, B.; Le, X.; Thorp, R.; Andry, C.; Duffy, E.R.; Lyadov, V.; Paklina, O.; Setdikova, G.; Shabunin, A.; Tavobilov, M.; McPherson, C.; Warnick, R.; Berkowitz, R.; Cramer, D.; Feltmate, C.; Horowitz, N.; Kibel, A.; Muto, M.; Raut, C.P.; Malykh, A.; Barnholtz-Sloan, J.S.; Barrett, W.; Devine, K.; Fulop, J.; Ostrom, Q.T.; Shimmel, K.; Wolinsky, Y.; Sloan, A.E.; De Rose, A.; Giuliante, F.; Goodman, M.; Karlan, B.Y.; Hagedorn, C.H.; Eckman, J.; Harr, J.; Myers, J.; Tucker, K.; Zach, L.A.; Deyarmin, B.; Hu, H.; Kvecher, L.; Larson, C.; Mural, R.J.; Somiari, S.; Vicha, A.; Zelinka, T.; Bennett, J.; Iacocca, M.; Rabeno, B.; Swanson, P.; Latour, M.; Lacombe, L.; Têtu, B.; Bergeron, A.; McGraw, M.; Staugaitis, S.M.; Chabot, J.; Hibshoosh, H.; Sepulveda, A.; Su, T.; Wang, T.; Potapova, O.; Voronina, O.; Desjardins, L.; Mariani, O.; Roman-Roman, S.; Sastre, X.; Stern, M-H.; Cheng, F.; Signoretti, S.; Berchuck, A.; Bigner, D.; Lipp, E.; Marks, J.; McCall, S.; McLendon, R.; Secord, A.; Sharp, A.; Behera, M.; Brat, D.J.; Chen, A.; Delman, K.; Force, S.; Khuri, F.; Magliocca, K.; Maithel, S.; Olson, J.J.; Owonikoko, T.; Pickens, A.; Ramalingam, S.; Shin, D.M.; Sica, G.; Van Meir, E.G.; Zhang, H.; Eijckenboom, W.; Gillis, A.; Korpershoek, E.; Looijenga, L.; Oosterhuis, W.; Stoop, H.; van Kessel, K.E.; Zwarthoff, E.C.; Calatozzolo, C.; Cuppini, L.; Cuzzubbo, S.; DiMeco, F.; Finocchiaro, G.; Mattei, L.; Perin, A.; Pollo, B.; Chen, C.; Houck, J.; Lohavanichbutr, P.; Hartmann, A.; Stoehr, C.; Stoehr, R.; Taubert, H.; Wach, S.; Wullich, B.; Kycler, W.; Murawa, D.; Wiznerowicz, M.; Chung, K.; Edenfield, W.J.; Martin, J.; Baudin, E.; Bubley, G.; Bueno, R.; De Rienzo, A.; Richards, W.G.; Kalkanis, S.; Mikkelsen, T.; Noushmehr, H.; Scarpace, L.; Girard, N.; Aymerich, M.; Campo, E.; Giné, E.; Guillermo, A.L.; Van Bang, N.; Hanh, P.T.; Phu, B.D.; Tang, Y.; Colman, H.; Evason, K.; Dottino, P.R.; Martignetti, J.A.; Gabra, H.; Juhl, H.; Akeredolu, T.; Stepa, S.; Hoon, D.; Ahn, K.; Kang, K.J.; Beuschlein, F.; Breggia, A.; Birrer, M.; Bell, D.; Borad, M.; Bryce, A.H.; Castle, E.; Chandan, V.; Cheville, J.; Copland, J.A.; Farnell, M.; Flotte, T.; Giama, N.; Ho, T.; Kendrick, M.; Kocher, J-P.; Kopp, K.; Moser, C.; Nagorney, D.; O’Brien, D.; O’Neill, B.P.; Patel, T.; Petersen, G.; Que, F.; Rivera, M.; Roberts, L.; Smallridge, R.; Smyrk, T.; Stanton, M.; Thompson, R.H.; Torbenson, M.; Yang, J.D.; Zhang, L.; Brimo, F.; Ajani, J.A.; Angulo Gonzalez, A.M.; Behrens, C.; Bondaruk, J.; Broaddus, R.; Czerniak, B.; Esmaeli, B.; Fujimoto, J.; Gershenwald, J.; Guo, C.; Lazar, A.J.; Logothetis, C.; Meric-Bernstam, F.; Moran, C.; Ramondetta, L.; Rice, D.; Sood, A.; Tamboli, P.; Thompson, T.; Troncoso, P.; Tsao, A.; Wistuba, I.; Carter, C.; Haydu, L.; Hersey, P.; Jakrot, V.; Kakavand, H.; Kefford, R.; Lee, K.; Long, G.; Mann, G.; Quinn, M.; Saw, R.; Scolyer, R.; Shannon, K.; Spillane, A.; Stretch, J.; Synott, M.; Thompson, J.; Wilmott, J.; Al-Ahmadie, H.; Chan, T.A.; Ghossein, R.; Gopalan, A.; Levine, D.A.; Reuter, V.; Singer, S.; Singh, B.; Tien, N.V.; Broudy, T.; Mirsaidi, C.; Nair, P.; Drwiega, P.; Miller, J.; Smith, J.; Zaren, H.; Park, J-W.; Hung, N.P.; Kebebew, E.; Linehan, W.M.; Metwalli, A.R.; Pacak, K.; Pinto, P.A.; Schiffman, M.; Schmidt, L.S.; Vocke, C.D.; Wentzensen, N.; Worrell, R.; Yang, H.; Moncrieff, M.; Goparaju, C.; Melamed, J.; Pass, H.; Botnariuc, N.; Caraman, I.; Cernat, M.; Chemencedji, I.; Clipca, A.; Doruc, S.; Gorincioi, G.; Mura, S.; Pirtac, M.; Stancul, I.; Tcaciuc, D.; Albert, M.; Alexopoulou, I.; Arnaout, A.; Bartlett, J.; Engel, J.; Gilbert, S.; Parfitt, J.; Sekhon, H.; Thomas, G.; Rassl, D.M.; Rintoul, R.C.; Bifulco, C.; Tamakawa, R.; Urba, W.; Hayward, N.; Timmers, H.; Antenucci, A.; Facciolo, F.; Grazi, G.; Marino, M.; Merola, R.; de Krijger, R.; Gimenez-Roqueplo, A-P.; Piché, A.; Chevalier, S.; McKercher, G.; Birsoy, K.; Barnett, G.; Brewer, C.; Farver, C.; Naska, T.; Pennell, N.A.; Raymond, D.; Schilero, C.; Smolenski, K.; Williams, F.; Morrison, C.; Borgia, J.A.; Liptay, M.J.; Pool, M.; Seder, C.W.; Junker, K.; Omberg, L.; Dinkin, M.; Manikhas, G.; Alvaro, D.; Bragazzi, M.C.; Cardinale, V.; Carpino, G.; Gaudio, E.; Chesla, D.; Cottingham, S.; Dubina, M.; Moiseenko, F.; Dhanasekaran, R.; Becker, K-F.; Janssen, K-P.; Slotta-Huspenina, J.; Abdel-Rahman, M.H.; Aziz, D.; Bell, S.; Cebulla, C.M.; Davis, A.; Duell, R.; Elder, J.B.; Hilty, J.; Kumar, B.; Lang, J.; Lehman, N.L.; Mandt, R.; Nguyen, P.; Pilarski, R.; Rai, K.; Schoenfield, L.; Senecal, K.; Wakely, P.; Hansen, P.; Lechan, R.; Powers, J.; Tischler, A.; Grizzle, W.E.; Sexton, K.C.; Kastl, A.; Henderson, J.; Porten, S.; Waldmann, J.; Fassnacht, M.; Asa, S.L.; Schadendorf, D.; Couce, M.; Graefen, M.; Huland, H.; Sauter, G.; Schlomm, T.; Simon, R.; Tennstedt, P.; Olabode, O.; Nelson, M.; Bathe, O.; Carroll, P.R.; Chan, J.M.; Disaia, P.; Glenn, P.; Kelley, R.K.; Landen, C.N.; Phillips, J.; Prados, M.; Simko, J.; Smith-McCune, K.; VandenBerg, S.; Roggin, K.; Fehrenbach, A.; Kendler, A.; Sifri, S.; Steele, R.; Jimeno, A.; Carey, F.; Forgie, I.; Mannelli, M.; Carney, M.; Hernandez, B.; Campos, B.; Herold-Mende, C.; Jungk, C.; Unterberg, A.; von Deimling, A.; Bossler, A.; Galbraith, J.; Jacobus, L.; Knudson, M.; Knutson, T.; Ma, D.; Milhem, M.; Sigmund, R.; Godwin, A.K.; Madan, R.; Rosenthal, H.G.; Adebamowo, C.; Adebamowo, S.N.; Boussioutas, A.; Beer, D.; Giordano, T.; Mes-Masson, A-M.; Saad, F.; Bocklage, T.; Landrum, L.; Mannel, R.; Moore, K.; Moxley, K.; Postier, R.; Walker, J.; Zuna, R.; Feldman, M.; Valdivieso, F.; Dhir, R.; Luketich, J.; Mora Pinero, E.M.; Quintero-Aguilo, M.; Carlotti, C.G., Jr; Dos Santos, J.S.; Kemp, R.; Sankarankuty, A.; Tirapelli, D.; Catto, J.; Agnew, K.; Swisher, E.; Creaney, J.; Robinson, B.; Shelley, C.S.; Godwin, E.M.; Kendall, S.; Shipman, C.; Bradford, C.; Carey, T.; Haddad, A.; Moyer, J.; Peterson, L.; Prince, M.; Rozek, L.; Wolf, G.; Bowman, R.; Fong, K.M.; Yang, I.; Korst, R.; Rathmell, W.K.; Fantacone-Campbell, J.L.; Hooke, J.A.; Kovatich, A.J.; Shriver, C.D.; DiPersio, J.; Drake, B.; Govindan, R.; Heath, S.; Ley, T.; Van Tine, B.; Westervelt, P.; Rubin, M.A.; Lee, J.I.; Aredes, N.D.; Mariamidze, A. Pan-cancer alterations of the MYC oncogene and its proximal network across the cancer genome atlas. Cell Syst., 2018, 6(3), 282-300.e2.
[http://dx.doi.org/10.1016/j.cels.2018.03.003] [PMID: 29596783]

Amati, B.; Brooks, M.W.; Levy, N.; Littlewood, T.D.; Evan, G.I.; Land, H. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell, 1993, 72(2), 233-245.
[http://dx.doi.org/10.1016/0092-8674(93)90663-B] [PMID: 8425220]

Soucek, L.; Whitfield, J.; Martins, C.P.; Finch, A.J.; Murphy, D.J.; Sodir, N.M.; Karnezis, A.N.; Swigart, L.B.; Nasi, S.; Evan, G.I. Modelling Myc inhibition as a cancer therapy. Nature, 2008, 455(7213), 679-683.
[http://dx.doi.org/10.1038/nature07260] [PMID: 18716624]

Beaulieu, M.E.; Martínez-Martín, S.; Kaur, J.; Castillo, C.V.; Massó-Vallés, D.; Foradada, F.L.; López-Estévez, S.; del Pozo, S.E.; Thabussot, H.; Soucek, L. Pharmacokinetic analysis of omomyc shows lasting structural integrity and long terminal half-life in tumor tissue. Cancers, 2023, 15(3), 826.
[http://dx.doi.org/10.3390/cancers15030826] [PMID: 36765784]

Rickman, D.S.; Schulte, J.H.; Eilers, M. The expanding world of N-MYC–driven tumors. Cancer Discov., 2018, 8(2), 150-163.
[http://dx.doi.org/10.1158/2159-8290.CD-17-0273] [PMID: 29358508]

Wistuba, I.; Gazdar, A.F.; Minna, J.D. Molecular genetics of small cell lung carcinoma. Semin. Oncol., 2001, 28(2), 3-13.
[http://dx.doi.org/10.1016/S0093-7754(01)90072-7] [PMID: 11479891]

Dhanasekaran, R.; Deutzmann, A.; Mahauad-Fernandez, W.D.; Hansen, A.S.; Gouw, A.M.; Felsher, D.W. The MYC oncogene — the grand orchestrator of cancer growth and immune evasion. Nat. Rev. Clin. Oncol., 2022, 19(1), 23-36.
[http://dx.doi.org/10.1038/s41571-021-00549-2] [PMID: 34508258]

Dhanasekaran, R.; Hansen, A.S.; Park, J.; Lemaitre, L.; Lai, I.; Adeniji, N.; Kuruvilla, S.; Suresh, A.; Zhang, J.; Swamy, V.; Felsher, D.W. MYC overexpression drives immune evasion in hepatocellular carcinoma that is reversible through restoration of proinflammatory macrophages. Cancer Res., 2023, 83(4), 626-640.
[http://dx.doi.org/10.1158/0008-5472.CAN-22-0232] [PMID: 36525476]

Soucek, L.; Helmer-Citterich, M.; Sacco, A.; Jucker, R.; Cesareni, G.; Nasi, S. Design and properties of a Myc derivative that efficiently homodimerizes. Oncogene, 1998, 17(19), 2463-2472.
[http://dx.doi.org/10.1038/sj.onc.1202199] [PMID: 9824157]

Demma, M.J.; Mapelli, C.; Sun, A.; Bodea, S.; Ruprecht, B.; Javaid, S.; Wiswell, D.; Muise, E.; Chen, S.; Zelina, J.; Orvieto, F.; Santoprete, A.; Altezza, S.; Tucci, F.; Escandon, E.; Hall, B.; Ray, K.; Walji, A.; O’Neil, J. Omomyc reveals new mechanisms to inhibit the MYC oncogene. Mol. Cell. Biol., 2019, 39(22), e00248-19.
[http://dx.doi.org/10.1128/MCB.00248-19] [PMID: 31501275]

Menssen, A.; Hermeking, H. Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci., 2002, 99(9), 6274-6279.
[http://dx.doi.org/10.1073/pnas.082005599] [PMID: 11983916]

Devaiah, B.N.; Case-Borden, C.; Gegonne, A.; Hsu, C.H.; Chen, Q.; Meerzaman, D.; Dey, A.; Ozato, K.; Singer, D.S. BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin. Nat. Struct. Mol. Biol., 2016, 23(6), 540-548.
[http://dx.doi.org/10.1038/nsmb.3228] [PMID: 27159561]

Kotekar, A.; Singh, A.K.; Devaiah, B.N. BRD4 and MYC: Power couple in transcription and disease. FEBS J., 2022, 290(20), 4820-4842.
[http://dx.doi.org/10.1111/febs.16580] [PMID: 35866356]

Ali, H.A.; Li, Y.; Bilal, A.H.M.; Qin, T.; Yuan, Z.; Zhao, W. A comprehensive review of BET protein biochemistry, physiology, and pathological roles. Front. Pharmacol., 2022, 13, 818891.
[http://dx.doi.org/10.3389/fphar.2022.818891] [PMID: 35401196]

Dey, A.; Ellenberg, J.; Farina, A.; Coleman, A.E.; Maruyama, T.; Sciortino, S.; Lippincott-Schwartz, J.; Ozato, K. A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition. Mol. Cell. Biol., 2000, 20(17), 6537-6549.
[http://dx.doi.org/10.1128/MCB.20.17.6537-6549.2000] [PMID: 10938129]

Devaiah, B.N.; Gegonne, A.; Singer, D.S. Bromodomain 4: A cellular Swiss army knife. J. Leukoc. Biol., 2016, 100(4), 679-686.
[http://dx.doi.org/10.1189/jlb.2RI0616-250R] [PMID: 27450555]

Devaiah, B.N.; Mu, J.; Akman, B.; Uppal, S.; Weissman, J.D.; Cheng, D.; Baranello, L.; Nie, Z.; Levens, D.; Singer, D.S. MYC protein stability is negatively regulated by BRD4. Proc. Natl. Acad. Sci., 2020, 117(24), 13457-13467.
[http://dx.doi.org/10.1073/pnas.1919507117] [PMID: 32482868]

Weissman, J.D.; Singh, A.K.; Devaiah, B.N.; Schuck, P.; LaRue, R.C.; Singer, D.S. The intrinsic kinase activity of BRD4 spans its BD2-B-BID domains. J. Biol. Chem., 2021, 297(5), 101326.
[http://dx.doi.org/10.1016/j.jbc.2021.101326] [PMID: 34688663]

Delmore, J.E.; Issa, G.C.; Lemieux, M.E.; Rahl, P.B.; Shi, J.; Jacobs, H.M.; Kastritis, E.; Gilpatrick, T.; Paranal, R.M.; Qi, J.; Chesi, M.; Schinzel, A.C.; McKeown, M.R.; Heffernan, T.P.; Vakoc, C.R.; Bergsagel, P.L.; Ghobrial, I.M.; Richardson, P.G.; Young, R.A.; Hahn, W.C.; Anderson, K.C.; Kung, A.L.; Bradner, J.E.; Mitsiades, C.S. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell, 2011, 146(6), 904-917.
[http://dx.doi.org/10.1016/j.cell.2011.08.017] [PMID: 21889194]

Kazi, A.; Xiang, S.; Yang, H.; Delitto, D.; Trevino, J.; Jiang, R.H.Y.; Ayaz, M.; Lawrence, H.R.; Kennedy, P.; Sebti, S.M. GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors. Nat. Commun., 2018, 9(1), 5154.
[http://dx.doi.org/10.1038/s41467-018-07644-6] [PMID: 30514931]

Grim, J.E.; Gustafson, M.P.; Hirata, R.K.; Hagar, A.C.; Swanger, J.; Welcker, M.; Hwang, H.C.; Ericsson, J.; Russell, D.W.; Clurman, B.E. Isoform- and cell cycle–dependent substrate degradation by the Fbw7 ubiquitin ligase. J. Cell Biol., 2008, 181(6), 913-920.
[http://dx.doi.org/10.1083/jcb.200802076] [PMID: 18559665]

Filippakopoulos, P.; Qi, J.; Picaud, S.; Shen, Y.; Smith, W.B.; Fedorov, O.; Morse, E.M.; Keates, T.; Hickman, T.T.; Felletar, I.; Philpott, M.; Munro, S.; McKeown, M.R.; Wang, Y.; Christie, A.L.; West, N.; Cameron, M.J.; Schwartz, B.; Heightman, T.D.; La Thangue, N.; French, C.A.; Wiest, O.; Kung, A.L.; Knapp, S.; Bradner, J.E. Selective inhibition of BET bromodomains. Nature, 2010, 468(7327), 1067-1073.
[http://dx.doi.org/10.1038/nature09504] [PMID: 20871596]

Mertz, J.A.; Conery, A.R.; Bryant, B.M.; Sandy, P.; Balasubramanian, S.; Mele, D.A.; Bergeron, L.; Sims, R.J., III Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc. Natl. Acad. Sci., 2011, 108(40), 16669-16674.
[http://dx.doi.org/10.1073/pnas.1108190108] [PMID: 21949397]

To, K.K.W.; Xing, E.; Larue, R.C.; Li, P.K. BET bromodomain inhibitors: Novel design strategies and therapeutic applications. Molecules, 2023, 28(7), 3043.
[http://dx.doi.org/10.3390/molecules28073043] [PMID: 37049806]

Han, X.; Sun, Y. PROTACs: A novel strategy for cancer drug discovery and development. MedComm, 2023, 4(3), e290.
[http://dx.doi.org/10.1002/mco2.290] [PMID: 37261210]

Raina, K.; Lu, J.; Qian, Y.; Altieri, M.; Gordon, D.; Rossi, A.M.K.; Wang, J.; Chen, X.; Dong, H.; Siu, K.; Winkler, J.D.; Crew, A.P.; Crews, C.M.; Coleman, K.G. PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Proc. Natl. Acad. Sci., 2016, 113(26), 7124-7129.
[http://dx.doi.org/10.1073/pnas.1521738113] [PMID: 27274052]

Li, Z.; Lim, S.L.; Tao, Y.; Li, X.; Xie, Y.; Yang, C.; Zhang, Z.; Jiang, Y.; Zhang, X.; Cao, X.; Wang, H.; Qian, G.; Wu, Y.; Li, M.; Fang, F.; Liu, Y.; Fu, M.; Ding, X.; Zhu, Z.; Lv, H.; Lu, J.; Xiao, S.; Hu, S.; Pan, J. PROTAC bromodomain inhibitor ARV-825 displays anti-tumor activity in neuroblastoma by repressing expression of MYCN or c-Myc. Front. Oncol., 2020, 10, 574525.
[http://dx.doi.org/10.3389/fonc.2020.574525] [PMID: 33324552]

Bernabé-Caro, R.; Chen, Y.; Dowlati, A.; Eason, P. Current and emerging treatment options for patients with relapsed small-cell lung carcinoma: A systematic literature review. Clin. Lung Cancer, 2023, 24(3), 185-208.
[http://dx.doi.org/10.1016/j.cllc.2023.01.012] [PMID: 36907793]

Pietanza, M.C.; Byers, L.A.; Minna, J.D.; Rudin, C.M. Small cell lung cancer: will recent progress lead to improved outcomes? Clin. Cancer Res., 2015, 21(10), 2244-2255.
[http://dx.doi.org/10.1158/1078-0432.CCR-14-2958] [PMID: 25979931]

George, J.; Lim, J.S.; Jang, S.J.; Cun, Y.; Ozretić, L.; Kong, G.; Leenders, F.; Lu, X.; Fernández-Cuesta, L.; Bosco, G.; Müller, C.; Dahmen, I.; Jahchan, N.S.; Park, K.S.; Yang, D.; Karnezis, A.N.; Vaka, D.; Torres, A.; Wang, M.S.; Korbel, J.O.; Menon, R.; Chun, S.M.; Kim, D.; Wilkerson, M.; Hayes, N.; Engelmann, D.; Pützer, B.; Bos, M.; Michels, S.; Vlasic, I.; Seidel, D.; Pinther, B.; Schaub, P.; Becker, C.; Altmüller, J.; Yokota, J.; Kohno, T.; Iwakawa, R.; Tsuta, K.; Noguchi, M.; Muley, T.; Hoffmann, H.; Schnabel, P.A.; Petersen, I.; Chen, Y.; Soltermann, A.; Tischler, V.; Choi, C.; Kim, Y.H.; Massion, P.P.; Zou, Y.; Jovanovic, D.; Kontic, M.; Wright, G.M.; Russell, P.A.; Solomon, B.; Koch, I.; Lindner, M.; Muscarella, L.A.; la Torre, A.; Field, J.K.; Jakopovic, M.; Knezevic, J.; Castaños-Vélez, E.; Roz, L.; Pastorino, U.; Brustugun, O.T.; Lund-Iversen, M.; Thunnissen, E.; Köhler, J.; Schuler, M.; Botling, J.; Sandelin, M.; Sanchez-Cespedes, M.; Salvesen, H.B.; Achter, V.; Lang, U.; Bogus, M.; Schneider, P.M.; Zander, T.; Ansén, S.; Hallek, M.; Wolf, J.; Vingron, M.; Yatabe, Y.; Travis, W.D.; Nürnberg, P.; Reinhardt, C.; Perner, S.; Heukamp, L.; Büttner, R.; Haas, S.A.; Brambilla, E.; Peifer, M.; Sage, J.; Thomas, R.K. Comprehensive genomic profiles of small cell lung cancer. Nature, 2015, 524(7563), 47-53.
[http://dx.doi.org/10.1038/nature14664] [PMID: 26168399]

Peifer, M.; Fernández-Cuesta, L.; Sos, M.L.; George, J.; Seidel, D.; Kasper, L.H.; Plenker, D.; Leenders, F.; Sun, R.; Zander, T.; Menon, R.; Koker, M.; Dahmen, I.; Müller, C.; Di Cerbo, V.; Schildhaus, H.U.; Altmüller, J.; Baessmann, I.; Becker, C.; de Wilde, B.; Vandesompele, J.; Böhm, D.; Ansén, S.; Gabler, F.; Wilkening, I.; Heynck, S.; Heuckmann, J.M.; Lu, X.; Carter, S.L.; Cibulskis, K.; Banerji, S.; Getz, G.; Park, K.S.; Rauh, D.; Grütter, C.; Fischer, M.; Pasqualucci, L.; Wright, G.; Wainer, Z.; Russell, P.; Petersen, I.; Chen, Y.; Stoelben, E.; Ludwig, C.; Schnabel, P.; Hoffmann, H.; Muley, T.; Brockmann, M.; Engel-Riedel, W.; Muscarella, L.A.; Fazio, V.M.; Groen, H.; Timens, W.; Sietsma, H.; Thunnissen, E.; Smit, E.; Heideman, D.A.M.; Snijders, P.J.F.; Cappuzzo, F.; Ligorio, C.; Damiani, S.; Field, J.; Solberg, S.; Brustugun, O.T.; Lund-Iversen, M.; Sänger, J.; Clement, J.H.; Soltermann, A.; Moch, H.; Weder, W.; Solomon, B.; Soria, J.C.; Validire, P.; Besse, B.; Brambilla, E.; Brambilla, C.; Lantuejoul, S.; Lorimier, P.; Schneider, P.M.; Hallek, M.; Pao, W.; Meyerson, M.; Sage, J.; Shendure, J.; Schneider, R.; Büttner, R.; Wolf, J.; Nürnberg, P.; Perner, S.; Heukamp, L.C.; Brindle, P.K.; Haas, S.; Thomas, R.K. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat. Genet., 2012, 44(10), 1104-1110.
[http://dx.doi.org/10.1038/ng.2396] [PMID: 22941188]

Rudin, C.M.; Poirier, J.T.; Byers, L.A.; Dive, C.; Dowlati, A.; George, J.; Heymach, J.V.; Johnson, J.E.; Lehman, J.M.; MacPherson, D.; Massion, P.P.; Minna, J.D.; Oliver, T.G.; Quaranta, V.; Sage, J.; Thomas, R.K.; Vakoc, C.R.; Gazdar, A.F. Molecular subtypes of small cell lung cancer: A synthesis of human and mouse model data. Nat. Rev. Cancer, 2019, 19(5), 289-297.
[http://dx.doi.org/10.1038/s41568-019-0133-9] [PMID: 30926931]

Patel, A.S.; Yoo, S.; Kong, R.; Sato, T.; Sinha, A.; Karam, S.; Bao, L.; Fridrikh, M.; Emoto, K.; Nudelman, G.; Powell, C.A.; Beasley, M.B.; Zhu, J.; Watanabe, H. Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer. Sci. Adv., 2021, 7(5), eabc2578.
[http://dx.doi.org/10.1126/sciadv.abc2578] [PMID: 33514539]

Brägelmann, J.; Böhm, S.; Guthrie, M.R.; Mollaoglu, G.; Oliver, T.G.; Sos, M.L. Family matters: How MYC family oncogenes impact small cell lung cancer. Cell Cycle, 2017, 16(16), 1489-1498.
[http://dx.doi.org/10.1080/15384101.2017.1339849] [PMID: 28737478]

Kaye, F.; Battey, J.; Nau, M.; Brooks, B.; Seifter, E.; De Greve, J.; Birrer, M.; Sausville, E.; Minna, J. Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing. Mol. Cell. Biol., 1988, 8(1), 186-195.
[PMID: 2827002]

Land, H.; Parada, L.F.; Weinberg, R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature, 1983, 304(5927), 596-602.
[http://dx.doi.org/10.1038/304596a0] [PMID: 6308472]

Massó-Vallés, D.; Beaulieu, M.E.; Soucek, L. MYC, MYCL, and MYCN as therapeutic targets in lung cancer. Expert Opin. Ther. Targets, 2020, 24(2), 101-114.
[http://dx.doi.org/10.1080/14728222.2020.1723548] [PMID: 32003251]

Saida, Y.; Watanabe, S.; Kikuchi, T. Extensive-stage small-cell lung cancer: Current landscape and future prospects. OncoTargets Ther., 2023, 16, 657-671.
[http://dx.doi.org/10.2147/OTT.S272552] [PMID: 37551311]

Kim, D.W.; Wu, N.; Kim, Y.C.; Cheng, P.F.; Basom, R.; Kim, D.; Dunn, C.T.; Lee, A.Y.; Kim, K.; Lee, C.S.; Singh, A.; Gazdar, A.F.; Harris, C.R.; Eisenman, R.N.; Park, K.S.; MacPherson, D. Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer. Genes Dev., 2016, 30(11), 1289-1299.
[http://dx.doi.org/10.1101/gad.279307.116] [PMID: 27298335]

Augert, A.; Mathsyaraja, H.; Ibrahim, A.H.; Freie, B.; Geuenich, M.J.; Cheng, P.F.; Alibeckoff, S.P.; Wu, N.; Hiatt, J.B.; Basom, R.; Gazdar, A.; Sullivan, L.B.; Eisenman, R.N.; MacPherson, D. MAX functions as a tumor suppressor and rewires metabolism in small cell lung cancer. Cancer Cell, 2020, 38(1), 97-114.e7.
[http://dx.doi.org/10.1016/j.ccell.2020.04.016] [PMID: 32470392]

Cani, M.; Napoli, V.M.; Garbo, E.; Ferrari, G.; Del Rio, B.; Novello, S.; Passiglia, F. Targeted therapies in small cell lung cancer: From old failures to novel therapeutic strategies. Int. J. Mol. Sci., 2023, 24(10), 8883.
[http://dx.doi.org/10.3390/ijms24108883] [PMID: 37240229]

Dammert, M.A.; Brägelmann, J.; Olsen, R.R.; Böhm, S.; Monhasery, N.; Whitney, C.P.; Chalishazar, M.D.; Tumbrink, H.L.; Guthrie, M.R.; Klein, S.; Ireland, A.S.; Ryan, J.; Schmitt, A.; Marx, A.; Ozretić, L.; Castiglione, R.; Lorenz, C.; Jachimowicz, R.D.; Wolf, E.; Thomas, R.K.; Poirier, J.T.; Büttner, R.; Sen, T.; Byers, L.A.; Reinhardt, H.C.; Letai, A.; Oliver, T.G.; Sos, M.L. MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer. Nat. Commun., 2019, 10(1), 3485.
[http://dx.doi.org/10.1038/s41467-019-11371-x] [PMID: 31375684]

Ireland, A.S.; Micinski, A.M.; Kastner, D.W.; Guo, B.; Wait, S.J.; Spainhower, K.B.; Conley, C.C.; Chen, O.S.; Guthrie, M.R.; Soltero, D.; Qiao, Y.; Huang, X.; Tarapcsák, S.; Devarakonda, S.; Chalishazar, M.D.; Gertz, J.; Moser, J.C.; Marth, G.; Puri, S.; Witt, B.L.; Spike, B.T.; Oliver, T.G. MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate. Cancer Cell, 2020, 38(1), 60-78.e12.
[http://dx.doi.org/10.1016/j.ccell.2020.05.001] [PMID: 32473656]

Ito, T.; Kudoh, S.; Fujino, K.; Sanada, M.; Tenjin, Y.; Saito, H.; Nakaishi-Fukuchi, Y.; Kameyama, H.; Ichimura, T.; Udaka, N.; Kudo, N.; Matsuo, A.; Sato, Y. Pulmonary neuroendocrine cells and small cell lung carcinoma: Immunohistochemical study focusing on mechanisms of neuroendocrine differentiation. Acta Histochem. Cytochem., 2022, 55(3), 75-83.
[http://dx.doi.org/10.1267/ahc.22-00031] [PMID: 35821751]

Borromeo, M.D.; Savage, T.K.; Kollipara, R.K.; He, M.; Augustyn, A.; Osborne, J.K.; Girard, L.; Minna, J.D.; Gazdar, A.F.; Cobb, M.H.; Johnson, J.E. ASCL1 and NEUROD1 reveal heterogeneity in pulmonary neuroendocrine tumors and regulate distinct genetic programs. Cell Rep., 2016, 16(5), 1259-1272.
[http://dx.doi.org/10.1016/j.celrep.2016.06.081] [PMID: 27452466]

McFadden, D.G.; Papagiannakopoulos, T.; Taylor-Weiner, A.; Stewart, C.; Carter, S.L.; Cibulskis, K.; Bhutkar, A.; McKenna, A.; Dooley, A.; Vernon, A.; Sougnez, C.; Malstrom, S.; Heimann, M.; Park, J.; Chen, F.; Farago, A.F.; Dayton, T.; Shefler, E.; Gabriel, S.; Getz, G.; Jacks, T. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell, 2014, 156(6), 1298-1311.
[http://dx.doi.org/10.1016/j.cell.2014.02.031] [PMID: 24630729]

Mollaoglu, G.; Guthrie, M.R.; Böhm, S.; Brägelmann, J.; Can, I.; Ballieu, P.M.; Marx, A.; George, J.; Heinen, C.; Chalishazar, M.D.; Cheng, H.; Ireland, A.S.; Denning, K.E.; Mukhopadhyay, A.; Vahrenkamp, J.M.; Berrett, K.C.; Mosbruger, T.L.; Wang, J.; Kohan, J.L.; Salama, M.E.; Witt, B.L.; Peifer, M.; Thomas, R.K.; Gertz, J.; Johnson, J.E.; Gazdar, A.F.; Wechsler-Reya, R.J.; Sos, M.L.; Oliver, T.G. MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to aurora kinase inhibition. Cancer Cell, 2017, 31(2), 270-285.
[http://dx.doi.org/10.1016/j.ccell.2016.12.005] [PMID: 28089889]

Christensen, C.L.; Kwiatkowski, N.; Abraham, B.J.; Carretero, J.; Al-Shahrour, F.; Zhang, T.; Chipumuro, E.; Herter-Sprie, G.S.; Akbay, E.A.; Altabef, A.; Zhang, J.; Shimamura, T.; Capelletti, M.; Reibel, J.B.; Cavanaugh, J.D.; Gao, P.; Liu, Y.; Michaelsen, S.R.; Poulsen, H.S.; Aref, A.R.; Barbie, D.A.; Bradner, J.E.; George, R.E.; Gray, N.S.; Young, R.A.; Wong, K.K. Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell, 2014, 26(6), 909-922.
[http://dx.doi.org/10.1016/j.ccell.2014.10.019] [PMID: 25490451]

Johnson, B.E.; Battey, J.; Linnoila, I.; Becker, K.L.; Makuch, R.W.; Snider, R.H.; Carney, D.N.; Minna, J.D. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. J. Clin. Invest., 1986, 78(2), 525-532.
[http://dx.doi.org/10.1172/JCI112604] [PMID: 3016030]

Kenzerki, M.E.; Ahmadi, M.; Mousavi, P.; Ghafouri-Fard, S. MYC and non-small cell lung cancer: A comprehensive review. Hum. Genet., 2023, 37, 201185.

Chen, J.; Guanizo, A.C.; Jakasekara, W.S.N.; Inampudi, C.; Luong, Q.; Garama, D.J.; Alamgeer, M.; Thakur, N.; DeVeer, M.; Ganju, V.; Watkins, D.N.; Cain, J.E.; Gough, D.J. MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat. J. Exp. Clin. Cancer Res., 2023, 42(1), 100.
[http://dx.doi.org/10.1186/s13046-023-02678-1] [PMID: 37098540]

Lenhart, R.; Kirov, S.; Desilva, H.; Cao, J.; Lei, M.; Johnston, K.; Peterson, R.; Schweizer, L.; Purandare, A.; Ross-Macdonald, P.; Fairchild, C.; Wong, T.; Wee, S. Sensitivity of small cell lung cancer to BET inhibition is mediated by regulation of ASCL1 gene expression. Mol. Cancer Ther., 2015, 14(10), 2167-2174.
[http://dx.doi.org/10.1158/1535-7163.MCT-15-0037] [PMID: 26253517]

Kumari, A.; Gesumaria, L.; Liu, Y.J.; Hughitt, V.K.; Zhang, X.; Ceribelli, M.; Wilson, K.M.; Klumpp-Thomas, C.; Chen, L.; McKnight, C.; Itkin, Z.; Thomas, C.J.; Mock, B.A.; Schrump, D.S.; Chen, H. mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer. JCI Insight, 2023, 8(5), e156657.
[http://dx.doi.org/10.1172/jci.insight.156657] [PMID: 36883564]

Chen, H.; Gesumaria, L.; Park, Y.K.; Oliver, T.G.; Singer, D.S.; Ge, K.; Schrump, D.S. BET inhibitors target the SCLC-N subtype of small-cell lung cancer by blocking NEUROD1 transactivation. Mol. Cancer Res., 2023, 21(2), 91-101.
[http://dx.doi.org/10.1158/1541-7786.MCR-22-0594] [PMID: 36378541]

Cochran, A.G.; Conery, A.R.; Sims, R.J., III Bromodomains: A new target class for drug development. Nat. Rev. Drug Discov., 2019, 18(8), 609-628.
[http://dx.doi.org/10.1038/s41573-019-0030-7] [PMID: 31273347]

Kato, F.; Fiorentino, F.P.; Alibés, A.; Perucho, M.; Sánchez-Céspedes, M.; Kohno, T.; Yokota, J. MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells. Oncotarget, 2016, 7(47), 77378-77388.
[http://dx.doi.org/10.18632/oncotarget.12671] [PMID: 27764802]

Nesbit, C.E.; Grove, L.E.; Yin, X.; Prochownik, E.V. Differential apoptotic behaviors of c-myc, N-myc, and L-myc oncoproteins. Cell Growth Differ., 1998, 9(9), 731-741.
[PMID: 9751117]

Berendsen, H.H.; de Leij, L.; de Vries, E.G.; Mesander, G.; Mulder, N.H.; de Jong, B.; Buys, C.H.; Postmus, P.E.; Poppema, S.; Sluiter, H.J. Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. Cancer Res., 1988, 48(23), 6891-6899.
[PMID: 2846164]

Savarese-Brenner, B.; Heugl, M.; Rath, B.; Schweizer, C.; Obermayr, E.; Stickler, S.; Hamilton, G. MUC1 and CD147 are promising markers for the detection of circulating tumor cells in small cell lung cancer. Anticancer Res., 2022, 42(1), 429-439.
[http://dx.doi.org/10.21873/anticanres.15501] [PMID: 34969753]

Singh, V.V.; Alauddin, S. Review on: BRD4 inhibitors for anticancer research. Hum. Genet., 2023, 37, 201196.

Wang, Y.W.; Lan, L.; Wang, M.; Zhang, J.Y.; Gao, Y.H.; Shi, L.; Sun, L.P. PROTACS: A technology with a gold rush-like atmosphere. Eur. J. Med. Chem., 2023, 247, 115037.
[http://dx.doi.org/10.1016/j.ejmech.2022.115037] [PMID: 36566716]

Liu, X.; Wang, A.; Shi, Y.; Dai, M.; Liu, M.; Cai, H.B. PROTACs in epigenetic cancer therapy: Current status and future opportunities. Molecules, 2023, 28(3), 1217.
[http://dx.doi.org/10.3390/molecules28031217] [PMID: 36770884]

Hamilton, G.; Stickler, S.; Rath, B. Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer. Explor. Target. Anti-tumor Ther., 2023, 1027-1038.
[http://dx.doi.org/10.37349/etat.2023.00178]